Moreover, the calibration curves demonstrate a good agreement between the predicted and observed probabilities of GPC3-positive HCC for both the training (P=0.342) and validation (P=0.101) datasets (Figure 5). This evidence concerns the gene GPC3 and hepatocellular carcinoma.